EXTENDED Drug Patent Profile
✉ Email this page to a colleague
When do Extended patents expire, and when can generic versions of Extended launch?
Extended is a drug marketed by Amneal Pharms Ny, Ani Pharms, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Taro, Unichem, Wockhardt, and Wockhardt Usa. and is included in eleven NDAs.
The generic ingredient in EXTENDED is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Extended
A generic version of EXTENDED was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for EXTENDED
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EXTENDED |
DailyMed Link: | EXTENDED at DailyMed |